SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Williams Nigel M.)
 

Sökning: WFRF:(Williams Nigel M.) > (2015-2019) > Barker Roger A > Statins are underus...

Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts

Swallow, Diane M A (författare)
Queen Elizabeth University Hospital
Lawton, Michael A (författare)
University of Bristol
Grosset, Katherine A (författare)
Queen Elizabeth University Hospital
visa fler...
Malek, Naveed (författare)
Queen Elizabeth University Hospital
Klein, Johannes (författare)
University of Oxford
Baig, Fahd (författare)
University of Oxford
Ruffmann, Claudio (författare)
University of Oxford
Bajaj, Nin P (författare)
Queen's Medical Centre, Nottingham
Barker, Roger A (författare)
Lund University,Lunds universitet,Utvecklings- och regenerativ neurobiologi,Forskargrupper vid Lunds universitet,Developmental and Regenerative Neurobiology,Lund University Research Groups
Ben-Shlomo, Yoav (författare)
University of Bristol
Burn, David J (författare)
University of Newcastle upon Tyne
Foltynie, Thomas (författare)
University College London
Morris, Huw R (författare)
University College London
Williams, Nigel (författare)
Cardiff University
Wood, Nicholas W (författare)
University College London
Hu, Michele T M (författare)
University of Oxford
Grosset, Donald G (författare)
Queen Elizabeth University Hospital
visa färre...
 (creator_code:org_t)
2016-09-26
2016
Engelska 8 s.
Ingår i: Journal of Neurology, Neurosurgery and Psychiatry. - : BMJ. - 1468-330X .- 0022-3050. ; 87:11, s. 1183-1190
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND: Cardiovascular disease (CVD) influences phenotypic variation in Parkinson's disease (PD), and is usually an indication for statin therapy. It is less clear whether cardiovascular risk factors influence PD phenotype, and if statins are prescribed appropriately.OBJECTIVES: To quantify vascular risk and statin use in recent-onset PD, and examine the relationship between vascular risk, PD severity and phenotype.METHODS: Cardiovascular risk was quantified using the QRISK2 calculator (high ≥20%, medium ≥10 and <20%, low risk <10%). Motor severity and phenotype were assessed using the Movement Disorder Society Unified PD Rating Scale (UPDRS) and cognition by the Montreal cognitive assessment.RESULTS: In 2909 individuals with recent-onset PD, the mean age was 67.5 years (SD 9.3), 63.5% were men and the mean disease duration was 1.3 years (SD 0.9). 33.8% of cases had high vascular risk, 28.7% medium risk, and 22.3% low risk, while 15.2% of cases had established CVD. Increasing vascular risk and CVD were associated with older age (p<0.001), worse motor score (p<0.001), more cognitive impairment (p<0.001) and worse motor phenotype (p=0.021). Statins were prescribed in 37.2% with high vascular risk, 15.1% with medium vascular risk and 6.5% with low vascular risk, which compared with statin usage in 75.3% of those with CVD.CONCLUSIONS: Over 60% of recent-onset PD patients have high or medium cardiovascular risk (meriting statin usage), which is associated with a worse motor and cognitive phenotype. Statins are underused in these patients, compared with those with vascular disease, which is a missed opportunity for preventive treatment.TRIAL REGISTRATION NUMBER: GN11NE062, NCT02881099.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Nyckelord

Parkinson disease
Statins

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy